ダウンストリームプロセスの世界市場：動向、予測、競合分析（～2030年）

世界のダウンストリームプロセスの市場規模は、2024～2030年にかけてCAGR 13.2%で成長し、2030年までに推定536億米ドルに達すると予測されています。この市場の主な促進要因は、バイオ医薬品セクターにおける研究開発費の伸び、バイオ医薬品需要の拡大、滅菌のための膜ろ過の利用拡大、ワクチンやバイオ医薬品の製造における濃縮技術の意義などです。バイオ医薬品メーカーと製造受託機関市場における機会により、世界のダウンストリームプロセス市場の将来は有望です。

ダウンストリームプロセス市場の洞察

Lucintelは、一流製品の製造に向けたダウンストリーム精製技術の進歩により、ワクチン製造が予測期間中最大のセグメントであり続けると予測しています。

この市場の中では、高齢者層の間でバイオ医薬品に対するニーズが高まっていることから、バイオ医薬品メーカーが最大セグメントであり続けると思われます。

アジア太平洋は、政府支援の増加、研究開発インフラの成熟化、専門知識と学術的成果のレベル向上により、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場規模は？

A1.世界のダウンストリームプロセス市場は、2030年までに推定536億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界のダウンストリームプロセス市場は、2024～2030年にかけてCAGR 13.2%で成長すると予測されています。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、バイオ医薬品セクターにおける研究開発費の伸び、バイオ医薬品需要の拡大、滅菌のための膜ろ過の利用拡大、ワクチンやバイオ医薬品の製造における濃縮技術の重要性です。

Q4.市場の主要セグメントは？

A4.ダウンストリームプロセス市場の将来は、バイオ医薬品メーカーと製造受託機関市場に機会があり、有望と思われます。

Q5.市場の主要企業は？

A5.主要なダウンストリームプロセス企業は以下の通り。

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、一流製品の製造のためのダウンストリーム精製技術の進歩により、ワクチン製造が予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.アジア太平洋は、政府支援の増加、研究開発インフラの成熟化、専門知識と学術的成果のレベル向上により、予測期間中最も高い成長が見込まれます。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のダウンストリームプロセス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のダウンストリームプロセスの市場動向（2018～2023年）と予測（2024～2030年）
• 世界のダウンストリームプロセス市場：技術別
  • 精製
  • 固液分離
  • 清澄/濃縮
• 世界のダウンストリームプロセス市場：製品別
  • クロマトグラフィーカラム・樹脂
  • フィルター
  • 膜吸着剤
  • 使い捨て製品
  • その他
• 世界のダウンストリームプロセス市場：用途別
  • モノクローナル抗体生産
  • ワクチン生産
  • インスリン生産
  • 免疫グロブリン生産
  • エリスロポエチン生産
  • その他
• 世界のダウンストリームプロセス市場：最終用途産業別
  • バイオ医薬品メーカー
  • 受託製造組織
  • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

• 世界のダウンストリームプロセス市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 技術別
  • 製品別
  • 用途別
  • 最終用途産業別
  • 地域別
• 世界のダウンストリームプロセス市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のダウンストリームプロセス市場の能力拡大
  • 世界のダウンストリームプロセス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Downstream Processing Trends and Forecast

The future of the global downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets. The global downstream processing market is expected to reach an estimated $53.6 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Downstream Processing by Segment

The study includes a forecast for the global downstream processing by technique, product, application, end use industry, and region.

Downstream Processing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

• Purification
• Solid-Liquid Separation
• Clarification/Concentration

Downstream Processing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Chromatography Columns & Resins
• Filters
• Membrane Adsorbers
• Single-Use Products
• Others

Downstream Processing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Monoclonal Antibody Production
• Vaccine Production
• Insulin Production
• Immunoglobulin Production
• Erythropoietin Production
• Others

Downstream Processing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Biopharmaceutical Manufacturers
• Contract Manufacturing Organizations
• Otherss

Downstream Processing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Downstream Processing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies downstream processing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the downstream processing companies profiled in this report include-

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Downstream Processing Market Insights

Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Within this market, biopharmaceutical manufacturers will remain the largest segment due to rising need for biopharmaceuticals among the elderly demographic.

APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Features of the Global Downstream Processing Market

Market Size Estimates: Downstream processing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Downstream processing market size by various segments, such as by technique, product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Downstream processing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technique, product, application, end use industry, and regions for the downstream processing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the downstream processing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the downstream processing market size?

Answer: The global downstream processing market is expected to reach an estimated $53.6 billion by 2030.

Q2. What is the growth forecast for downstream processing market?

Answer: The global downstream processing market is expected to grow with a CAGR of 13.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the downstream processing market?

Answer: The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

Q4. What are the major segments for downstream processing market?

Answer: The future of the downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets.

Q5. Who are the key downstream processing market companies?

Answer: Some of the key downstream processing companies are as follows.

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Q6. Which downstream processing market segment will be the largest in future?

Answer: Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Q7. In downstream processing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the downstream processing market by technique (purification, solid-liquid separation, and clarification/concentration), product (chromatography columns & resins, filters, membrane adsorbers, single-use products, and others), application (monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and others), end use industry (biopharmaceutical manufacturers, contract manufacturing organizations, and otherss), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Downstream Processing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Downstream Processing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Downstream Processing Market by Technique
  • 3.3.1: Purification
  • 3.3.2: Solid-Liquid Separation
  • 3.3.3: Clarification/Concentration
• 3.4: Global Downstream Processing Market by Product
  • 3.4.1: Chromatography Columns & Resins
  • 3.4.2: Filters
  • 3.4.3: Membrane Adsorbers
  • 3.4.4: Single-Use Products
  • 3.4.5: Others
• 3.5: Global Downstream Processing Market by Application
  • 3.5.1: Monoclonal Antibody Production
  • 3.5.2: Vaccine Production
  • 3.5.3: Insulin Production
  • 3.5.4: Immunoglobulin Production
  • 3.5.5: Erythropoietin Production
  • 3.5.6: Others
• 3.6: Global Downstream Processing Market by End Use Industry
  • 3.6.1: Biopharmaceutical Manufacturers
  • 3.6.2: Contract Manufacturing Organizations
  • 3.6.3: Otherss

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Downstream Processing Market by Region
• 4.2: North American Downstream Processing Market
  • 4.2.2: North American Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
• 4.3: European Downstream Processing Market
  • 4.3.1: European Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • 4.3.2: European Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
• 4.4: APAC Downstream Processing Market
  • 4.4.1: APAC Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • 4.4.2: APAC Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
• 4.5: ROW Downstream Processing Market
  • 4.5.1: ROW Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • 4.5.2: ROW Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Downstream Processing Market by Technique
  • 6.1.2: Growth Opportunities for the Global Downstream Processing Market by Product
  • 6.1.3: Growth Opportunities for the Global Downstream Processing Market by Application
  • 6.1.4: Growth Opportunities for the Global Downstream Processing Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Downstream Processing Market by Region
• 6.2: Emerging Trends in the Global Downstream Processing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Downstream Processing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Downstream Processing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: GE Healthcare
• 7.3: Sartorius Stedim Biotech
• 7.4: Merck Millipore
• 7.5: Danaher
• 7.6: 3M
• 7.7: Boehringer Ingelheim
• 7.8: Lonza
• 7.9: Eppendorf
• 7.10: Finesse Solutions